poisar

Stocks · News reference

Indaptus Therapeutics Announces Private Placement Of 20,338,974 Shares For Gross Proceeds Of ~$24M

BenzingaBenzinga Newsdesk

The Company currently intends to use the net proceeds from the Private Placement for working capital, research and development and other general corporate purposes, which may include early-stage research and preclinical

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading